170 related articles for article (PubMed ID: 8714798)
1. Safety aspects of cyclosporin in rheumatoid arthritis.
Dijkmans BA
Drugs; 1995; 50 Suppl 1():41-7. PubMed ID: 8714798
[TBL] [Abstract][Full Text] [Related]
2. International consensus recommendations on cyclosporin use in rheumatoid arthritis.
Tugwell P
Drugs; 1995; 50 Suppl 1():48-56. PubMed ID: 8714799
[TBL] [Abstract][Full Text] [Related]
3. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
Yocum DE; Allard S; Cohen SB; Emery P; Flipo RM; Goobar J; Jayawardena S; Job-Deslandre C; Jubb RW; Krüger K; Lopes Vaz A; Manger B; Mur E; Nygaard H; Weiner SM; Rainer F; Sack MR; Schiff MH; Schnitzer TJ; Trigg LB; Whatmough I; Schmidt AG
Rheumatology (Oxford); 2000 Feb; 39(2):156-64. PubMed ID: 10725065
[TBL] [Abstract][Full Text] [Related]
4. The use of Neoral in rheumatoid arthritis.
Cranney A; Tugwell P
Rheum Dis Clin North Am; 1998 Aug; 24(3):479-88. PubMed ID: 9710882
[TBL] [Abstract][Full Text] [Related]
5. Neoral--new cyclosporin for old?
Somerville MF; Scott DG
Br J Rheumatol; 1997 Oct; 36(10):1113-5. PubMed ID: 9374930
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of cyclosporin in rheumatoid arthritis.
Richardson C; Emery P
Drugs; 1995; 50 Suppl 1():26-36. PubMed ID: 8714796
[TBL] [Abstract][Full Text] [Related]
7. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Anderson IF; Helve T; Hannonen P; Leirisalo-Repo M; Gilboe IM; Nissilä M; Keystone EC; Kraag GR; Bjørneboe O; Chalmers A; Dovland H; Mueller E; Richard F; Whatmough I; Schmidt AG; Kovarik JM
J Rheumatol; 1999 Mar; 26(3):556-62. PubMed ID: 10090162
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of conversion from stable Sandimmun maintenance treatment to Sandimmun Neoral in patients with rheumatoid arthritis.
Flipo RM; Emery P; Scott DG; Situnayake RD; Prowse PJ; James DW; Cawley MI; Whatmough I; Schmidt AG
J Rheumatol; 1998 Jul; 25(7):1263-9. PubMed ID: 9676754
[TBL] [Abstract][Full Text] [Related]
9. Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry.
Rodríguez F; Krayenbühl JC; Harrison WB; Førre O; Dijkmans BA; Tugwell P; Miescher PA; Mihatsch MJ
Arthritis Rheum; 1996 Sep; 39(9):1491-8. PubMed ID: 8814060
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss.
van den Borne BE; Landewé RB; Goei The HS; Breedveld FC; Dijkmans BA
Rheumatology (Oxford); 1999 Mar; 38(3):254-9. PubMed ID: 10325664
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with cyclosporin in rheumatoid arthritis.
Yocum DE
Drugs; 1995; 50 Suppl 1():37-40. PubMed ID: 8714797
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin in rheumatoid arthritis: monitoring for adverse effects and clinically significant drug interactions.
Dijkmans B; Gerards A
BioDrugs; 1998 Dec; 10(6):437-45. PubMed ID: 18020613
[TBL] [Abstract][Full Text] [Related]
14. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
Coukell AJ; Plosker GL
Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420
[TBL] [Abstract][Full Text] [Related]
16. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension.
Kvien TK; Zeidler HK; Hannonen P; Wollheim FA; Førre O; Hafström I; Kaltwasser JP; Leirisalo-Repo M; Manger B; Laasonen L; Prestele H; Kurki P
Ann Rheum Dis; 2002 Jun; 61(6):511-6. PubMed ID: 12006323
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
Noble S; Markham A
Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
[TBL] [Abstract][Full Text] [Related]
18. The use of Sandimmun (cyclosporin A) in severe refractory rheumatoid arthritis: the Belgian experience.
Malaise MG; De Keyser P; De Backer M; van Lierde MA; Lesaffre E
Clin Rheumatol; 1995 Sep; 14 Suppl 2():26-32. PubMed ID: 8846651
[TBL] [Abstract][Full Text] [Related]
19. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
Br J Rheumatol; 1993 Mar; 32 Suppl 1():65-71. PubMed ID: 8448642
[TBL] [Abstract][Full Text] [Related]
20. Long-term cyclosporin continuation rates in rheumatoid arthritis patients.
Carpentier N; Bertin P; Druet-Cabanac M; Abdeddaïm M; Vergne P; Bonnet C; Trèves R
Rev Rhum Engl Ed; 1999 May; 66(5):245-9. PubMed ID: 10380255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
